Stockholder's Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended				12 Months Ended
	Jan. 21, 2020	Jun. 04, 2019	Jan. 31, 2020	Jan. 21, 2020	Jul. 29, 2019	Jun. 04, 2019	Dec. 31, 2019	Dec. 31, 2018	Apr. 30, 2019	Feb. 28, 2019	Jul. 17, 2014
Stockholders' Equity (Deficiency) (Textual)
Shares issued of common stock							80,000		275,300	145,300
Par value		$ 0.001				$ 0.001
Conversion of preferred warrants		4,772,727
Aggregate gross proceeds		$ 7,000			$ 5,250
Cumulative cash dividends payable, description		Commencing on March 31, 2020, cumulative cash dividends shall become payable on the Preferred Stock at the rate per share of 7% per annum, which rate shall increase to 14% per annum on June 30, 2020.
Preferred warrants exercise price		$ 1.01				$ 1.01
Stock based compensation							$ 61	$ 377
Expected dividend yield							0.00%
Expected volatility rate							48.61%	37.30%
Risk-free interest rate							2.60%	281.00%
Expected term							6 years 6 months	6 years
Total expenses of options							$ 61
Received additional amount							1,200
Aggregate amount								$ 3,004
Convertible Notes Payable [Member] | Securities Purchase Agreement [Member]
Stockholders' Equity (Deficiency) (Textual)
Sale of stock						2,727,272
Purchase amount of convertible notes from company						$ 2,000
Additional amount increased by BNN						$ 1,000
Warrants to purchase of common stock						2,727,272
Convertible notes, terms						2 years
Aggregate number of common share, percentage		100.00%				100.00%
Subsequent Event [Member]
Stockholders' Equity (Deficiency) (Textual)
Received additional amount			$ 550
Board of Directors [Member]
Stockholders' Equity (Deficiency) (Textual)
Options grant							30,000
Options, exercise price							$ 1.32
Fair value of grants							$ 0
2012 Stock Incentive Plan [Member]
Stockholders' Equity (Deficiency) (Textual)
Stock based compensation							$ 61	$ 377
Number of shares available for future awards							3,652,400
Expiration term							10 years
2014 Stock Incentive Plan [Member]
Stockholders' Equity (Deficiency) (Textual)
Number of shares available for future awards							76,775
Number of shares authorized											100,000
Common stock reserved for issuance											600,000
Preferred Stock [Member]
Stockholders' Equity (Deficiency) (Textual)
Total expenses					$ 420
Sale of stock					2,386,363
Conversion of preferred stock		6,366,363				6,366,363
Warrant [Member]
Stockholders' Equity (Deficiency) (Textual)
Sale of stock					3,579,544
Warrant [Member] | Convertible Notes Payable [Member]
Stockholders' Equity (Deficiency) (Textual)
Acquisitions description		The Note Warrants shall have an exercise price of $1.01 (subject to customary adjustment in the event of future stock dividends, splits and the like), and shall be exercisable immediately upon receipt of stockholder approval of the Convertible Note Offering, until the earlier of (i) two years from the date of issuance or (ii) the later of (a) 180 days after the closing by the Company of a change of control transaction, or (b) the company’s next debt or equity financing of at least $20 million.
Warrant [Member] | Subsequent Event [Member] | Convertible Notes Payable [Member]
Stockholders' Equity (Deficiency) (Textual)
Debt conversion, description	Pursuant to which BNN agreed to convert the outstanding convertible note, issued on July 31, 2019, into 1,818,181 shares of the Company’s newly-designated Series B Preferred Stock, par value $0.001 per share, with a stated value of $1.10 per share (the “Series B Preferred”) (collectively, the “Conversion”). In accordance with the Conversion, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred with the Secretary of State of the State of Delaware on January 21, 2020 to designate the rights and preferences of up to 1,818,181 shares of Series B Preferred.			Pursuant to which BNN agreed to convert the outstanding convertible note, issued on July 31, 2019, into 1,818,181 shares of the Company’s newly-designated Series B Preferred Stock, par value $0.001 per share, with a stated value of $1.10 per share (the “Series B Preferred”) (collectively, the “Conversion”). In accordance with the Conversion, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred with the Secretary of State of the State of Delaware on January 21, 2020 to designate the rights and preferences of up to 1,818,181 shares of Series B Preferred.
Series A Convertible Preferred Stock [Member]
Stockholders' Equity (Deficiency) (Textual)
Sale of stock		3,181,818
Stated value of per share		$ 2.20				$ 2.20
Convertible Preferred Stock [Member] | Warrant [Member]
Stockholders' Equity (Deficiency) (Textual)
Acquisitions description		The Preferred Warrants shall have an exercise price of $1.01 (subject to customary adjustment in the event of future stock dividends, splits and the like), which is above the average price of the Common Stock during the preceding five trading days, and shall be exercisable immediately, until the earlier of (i) two years from the date of issuance or (ii) the later of (a) 180 days after the closing by the Company of a change of control transaction, or (b) the company’s next debt or equity financing of at least $20 million.